is one of the most widely used cervical discs in the world. First implanted in France in November 2004, Mobi-C has been implanted in more than 75,000 spinal levels in 25 countries. A total of 599 ...
Not long ago, patients with cervical disc problems in their spine received a spinal fusion to relieve the pain. Now, with the release of a new device, the Mobi-C is an option for many. It is the first ...
AUSTIN, Texas--(BUSINESS WIRE)--LDR, a privately held medical device company offering exclusive spinal implant technologies for both non-fusion and fusion applications, today announced that it has ...
WESTMINSTER, Colo., Oct. 31, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (ZIMV), a global life sciences leader in the dental and spine markets, today announced that the first patient in the United States has ...
Please provide your email address to receive an email when new articles are posted on . LDR announced completion of the 24-month follow-up phase of its two-level IDE study on the Mobi-C cervical ...
Please provide your email address to receive an email when new articles are posted on . After a review by its Medical Policy & Technology Assessment Committee, Anthem Blue Cross/Blue Shield updated ...
Zimmer Biomet Holdings, Inc. announced results of a seven-year outcomes study demonstrating statistical superiority of its Mobi-C Cervical Disc Prosthesis versus two-level anterior cervical discectomy ...
WESTMINSTER, Colo., Jan. 30, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that over 200,000 Mobi-C Cervical Discs ...
Austin, Texas-based LDR’s Mobi-C Cervical Disc has been approved by the FDA for two-level indications, making it the only cervical disc in the country approved to treat more than one level in the ...
AUSTIN, Texas--(BUSINESS WIRE)--LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced that it has received an ...
Spinal implant specialist LDR has been held back by patchy insurance company reimbursement of its flagship device, demonstrating the challenges facing med tech companies as they navigate the tricky ...